标题
Orthologous CRISPR–Cas9 enzymes for combinatorial genetic screens
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume 36, Issue 2, Pages 179-189
出版商
Springer Nature
发表日期
2017-12-19
DOI
10.1038/nbt.4048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
- (2017) Kyuho Han et al. NATURE BIOTECHNOLOGY
- Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactions
- (2017) John Paul Shen et al. NATURE METHODS
- A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response
- (2016) Britt Adamson et al. CELL
- A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy
- (2016) Rohith Srivas et al. MOLECULAR CELL
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library
- (2016) Shiyou Zhu et al. NATURE BIOTECHNOLOGY
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array
- (2016) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Complex transcriptional modulation with orthogonal and inducible dCas9 regulators
- (2016) Yuchen Gao et al. NATURE METHODS
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
- (2016) Alan S. L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A global genetic interaction network maps a wiring diagram of cellular function
- (2016) M. Costanzo et al. SCIENCE
- A High-Throughput Strategy for Dissecting Mammalian Genetic Interactions
- (2016) Victoria B. Stockman et al. PLoS One
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
- (2015) GEORGE MIHAI NITULESCU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
- (2015) Benjamin P Kleinstiver et al. NATURE BIOTECHNOLOGY
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation
- (2015) Asaf Rotem et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries
- (2015) Joana A. Vidigal et al. Nature Communications
- Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
- (2014) R. W. Rooswinkel et al. BLOOD
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function
- (2014) S B Ma et al. CELL DEATH AND DIFFERENTIATION
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation
- (2014) John G Doench et al. NATURE BIOTECHNOLOGY
- Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
- (2014) Chong Sun et al. TRENDS IN BIOCHEMICAL SCIENCES
- A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility
- (2013) Michael C. Bassik et al. CELL
- CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo
- (2013) L. Chaudhuri et al. HAEMATOLOGICA
- BID Preferentially Activates BAK while BIM Preferentially Activates BAX, Affecting Chemotherapy Response
- (2013) Kristopher A. Sarosiek et al. MOLECULAR CELL
- BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation
- (2013) Britta Stordal et al. Molecular Oncology
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- Inactivating CUX1 mutations promote tumorigenesis
- (2013) Chi C Wong et al. NATURE GENETICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Quantitative genetic-interaction mapping in mammalian cells
- (2013) Assen Roguev et al. NATURE METHODS
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- Mapping of signaling networks through synthetic genetic interaction analysis by RNAi
- (2011) Thomas Horn et al. NATURE METHODS
- Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition
- (2008) Olivier ter Brake et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search